United States Federal Circuit
Eli Lilly & Co. v. Teva Parental Medicines, Inc., 11-1561
In a patent infringement suit related to applications filed by several generic pharmaceutical manufacturers seeking regulatory approval to market generic formulations of the chemotherapy agent pemetrexed, district court's holding that the patent is not invalid for obviousness-type double patenting over two earlier-issued claims is affirmed and defendants' remaining arguments are without merit.
Appellate Information
- Decided 08/24/2012
- Published 08/24/2012
Judges
- Lourier
Court
- United States Federal Circuit